214 related articles for article (PubMed ID: 24528599)
1. Dickkopf-1 is regulated by the mevalonate pathway in breast cancer.
Rachner TD; Göbel A; Thiele S; Rauner M; Benad-Mehner P; Hadji P; Bauer T; Muders MH; Baretton GB; Jakob F; Ebert R; Bornhäuser M; Schem C; Hofbauer LC
Breast Cancer Res; 2014 Feb; 16(1):R20. PubMed ID: 24528599
[TBL] [Abstract][Full Text] [Related]
2. Potentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins.
Göbel A; Browne AJ; Thiele S; Rauner M; Hofbauer LC; Rachner TD
Breast Cancer Res Treat; 2015 Dec; 154(3):623-31. PubMed ID: 26515701
[TBL] [Abstract][Full Text] [Related]
3. Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells.
Göbel A; Thiele S; Browne AJ; Rauner M; Zinna VM; Hofbauer LC; Rachner TD
Cancer Lett; 2016 May; 375(1):162-171. PubMed ID: 26968247
[TBL] [Abstract][Full Text] [Related]
4. Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial.
Anastasilakis AD; Polyzos SA; Gkiomisi A; Bisbinas I; Gerou S; Makras P
J Clin Endocrinol Metab; 2013 Aug; 98(8):3206-12. PubMed ID: 23788684
[TBL] [Abstract][Full Text] [Related]
5. p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells.
Browne AJ; Göbel A; Thiele S; Hofbauer LC; Rauner M; Rachner TD
Cell Death Dis; 2016 Feb; 7(2):e2119. PubMed ID: 26913608
[TBL] [Abstract][Full Text] [Related]
6. P38 regulates the Wnt inhibitor Dickkopf-1 in breast cancer.
Rachner TD; Göbel A; Browne A; Hötzel J; Rauner M; Hofbauer LC
Biochem Biophys Res Commun; 2015 Oct; 466(4):728-32. PubMed ID: 26407843
[TBL] [Abstract][Full Text] [Related]
7. An unexpected role for a Wnt-inhibitor: Dickkopf-1 triggers a novel cancer survival mechanism through modulation of aldehyde-dehydrogenase-1 activity.
Krause U; Ryan DM; Clough BH; Gregory CA
Cell Death Dis; 2014 Feb; 5(2):e1093. PubMed ID: 24577091
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer.
Göbel A; Zinna VM; Dell'Endice S; Jaschke N; Kuhlmann JD; Wimberger P; Rachner TD
BMC Cancer; 2020 Jul; 20(1):703. PubMed ID: 32727400
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastases.
Bu G; Lu W; Liu CC; Selander K; Yoneda T; Hall C; Keller ET; Li Y
Int J Cancer; 2008 Sep; 123(5):1034-42. PubMed ID: 18546262
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF.
Fujita K; Janz S
Mol Cancer; 2007 Oct; 6():71. PubMed ID: 17971207
[TBL] [Abstract][Full Text] [Related]
11. Distinct mechanisms of bisphosphonate action between osteoblasts and breast cancer cells: identity of a potent new bisphosphonate analogue.
Reinholz GG; Getz B; Sanders ES; Karpeisky MY; Padyukova NSh; Mikhailov SN; Ingle JN; Spelsberg TC
Breast Cancer Res Treat; 2002 Feb; 71(3):257-68. PubMed ID: 12002344
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Rho and Rac geranylgeranylation by atorvastatin is critical for preservation of endothelial junction integrity.
Xiao H; Qin X; Ping D; Zuo K
PLoS One; 2013; 8(3):e59233. PubMed ID: 23555637
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate-induced ATP analog formation and its effect on inhibition of cancer cell growth.
Mönkkönen H; Kuokkanen J; Holen I; Evans A; Lefley DV; Jauhiainen M; Auriola S; Mönkkönen J
Anticancer Drugs; 2008 Apr; 19(4):391-9. PubMed ID: 18454049
[TBL] [Abstract][Full Text] [Related]
14. Death receptor 5 agonist TRA8 in combination with the bisphosphonate zoledronic acid attenuated the growth of breast cancer metastasis.
Szafran AA; Folks K; Warram J; Chanda D; Wang D; Zinn KR
Cancer Biol Ther; 2009 Jun; 8(12):1109-16. PubMed ID: 19652526
[TBL] [Abstract][Full Text] [Related]
15. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
[TBL] [Abstract][Full Text] [Related]
16. The kinetochore protein Cenp-F is a potential novel target for zoledronic acid in breast cancer cells.
Brown HK; Ottewell PD; Coleman RE; Holen I
J Cell Mol Med; 2011 Mar; 15(3):501-13. PubMed ID: 20015195
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts.
Viereck V; Gründker C; Blaschke S; Frosch KH; Schoppet M; Emons G; Hofbauer LC
J Cell Biochem; 2005 Dec; 96(6):1244-53. PubMed ID: 16152630
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer cells promote osteoblastic bone metastases through Wnts.
Hall CL; Bafico A; Dai J; Aaronson SA; Keller ET
Cancer Res; 2005 Sep; 65(17):7554-60. PubMed ID: 16140917
[TBL] [Abstract][Full Text] [Related]
19. Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonates.
Thiele S; Rauner M; Goettsch C; Rachner TD; Benad P; Fuessel S; Erdmann K; Hamann C; Baretton GB; Wirth MP; Jakob F; Hofbauer LC
J Cell Biochem; 2011 Jun; 112(6):1593-600. PubMed ID: 21344486
[TBL] [Abstract][Full Text] [Related]
20. Dorsomorphin: A novel inhibitor of Dickkopf-1 in breast cancer.
Jaschke N; Kleymann A; Hofbauer LC; Göbel A; Rachner TD
Biochem Biophys Res Commun; 2020 Apr; 524(2):360-365. PubMed ID: 32001001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
